ELAN Stock Price, Chart, Stats & News
Elanco Animal Health Incorporated (ELAN) does not currently pay a dividend.
ELAN chart
Fundamentals
Gross margin | 46.45% |
Operating margin | 5.34% |
Pretax margin | -4.75% |
Net margin | -4.92% |
Effective tax rate | -3.57% |
ROA | -1.74% |
ROE | -3.51% |
D/E | 0.61x |
Interest coverage ratio | 0.95x |
ELAN valuation
P/E | 25.33x |
P/S | 2.44x |
P/B | 1.75x |
P/CF | 20.51x |
P/FCF | 40.46x |
P/OCF | 20.51x |
PEG | 0.07x |
EV multiple | 11.10x |
About
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro.
Similar securities
Based on sector and market capitalization
